|

EBV-specific T cells: A Clinical Trials

1 actively recruiting trial across 1 location

Also known as: LMP, BARF1 and EBNA1 specific CTLs

Houston, Texas1 trial

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

Harris Health System (includes ben Taub General Hospital and Smith)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.